SCHEMBL20151467

SCHEMBL20151467

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2ccc3c4ccccc4n(-c4nc5ccccc5c5nc6ccccc6n45)c3c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.47
HPGD P15428 6/20 0.47
ALDH1A1 P00352 5/20 0.47
KMT2A Q03164 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 4/20 0.42
POLB P06746 2/20 0.42
HSD17B10 Q99714 2/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
MEN1 O00255 3/20 0.40
GAA P10253 1/20 0.35
HIF1A Q16665 1/20 0.35
CAMKK1 Q8N5S9 2/20 0.34
CAMKK2 Q96RR4 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20151481 0.96 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151040 0.96 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151489 0.96 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151020 0.96 KDM4E (0.49) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151044 0.94 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151060 0.94 KDM4E (0.50) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151038 0.93 KDM4E (0.48) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL23467483 0.92 KDM4E (0.48) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151054 0.92 KDM4E (0.48) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2
SCHEMBL20151474 0.92 KDM4E (0.48) KDM4EHPGDALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11031560-B2 Compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-06-08 US disclosed
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11031560-B2 Compound and organic electronic element comprising same OR10J3, ESR1, ETV6 KDM4E 847/4885HPGD 4158/4885ALDH1A1 1081/4885
US-20180138422-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ESR1, ETV6 KDM4E 847/4885HPGD 4158/4885ALDH1A1 1081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.